Investigation of the influence of the new coronavirus pandemic (COVID-19) on pain, mood and everyday life of patients with painful polyneuropathy

Investigation of the influence of the new coronavirus pandemic (COVID-19) on pain, mood and everyday life of patients with painful polyneuropathy - COSOPA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021254

Enrollment

Registered

2020-04-03

Start date

2020-04-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

painful polyneuropathy G60-G64

Interventions

Group 1: patients with painful polyneuropathy Evaluation of questionnaires (DN4, BPI, PainDETECT, PROMIS, EuroQol 5D, Pain catastrophizing scale, IPAQ, PGIC)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: diagnosis of painful polyneuropathy

Exclusion criteria

Exclusion criteria: not able to give independent consent

Design outcomes

Primary

Measure	Time frame
Pain development during the corona crisis. End: as soon as the measures are cancelled and daily life can take place again as before with which: the assessment is carried out using the questionnaires mentioned	—

Secondary

Measure	Time frame
Change of parameters that are evaluated using all mentioned questionnaires - general health, functionality, depression, anxiety.	—

Countries

Germany

Contacts

Public ContactDilara Kersebaum

Universitätsklinikum Schleswig-Holstein, Campus KielKlinik für Neurologie Sektion Neurologische Schmerzforschung und -therapie

dilara.kersebaum@uksh.de043150023911

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026